REGISTERED NUMBER: 11912924 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Elysium Medical Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Ms E Day

R G Paul

SECRETARY:

Ms E Day

REGISTERED OFFICE:

Netley House, Shere Road

Gomshall, Guildford

Surrey

GU5 9QA

REGISTERED NUMBER:

11912924 (England and Wales)

ACCOUNTANTS:

Tempus Tax Ltd

The Place

Turner House

9-10 Mill Lane

Alton

Hampshire

GU3 4QG

FIXED ASSETS

Tangible assets

4

24,360

18,748

Investments

5

20

20

24,380

18,768

CURRENT ASSETS

Debtors

6

12,451

11,481

Cash at bank

259,793

221,813

272,244

233,294

CREDITORS

Amounts falling due within one year

7

13,846

(6,462

)

NET CURRENT ASSETS

258,398

239,756

TOTAL ASSETS LESS CURRENT LIABILITIES

282,778

258,524

CREDITORS

Amounts falling due after more than one year

8

-

23,425

NET ASSETS

282,778

235,099

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

282,678

234,999

282,778

235,099

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 July 2025 and were signed on its behalf by:

R G Paul - Director

1.	STATUTORY INFORMATION

Elysium Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

40,290

Additions

11,221

At 31 March 2025

51,511

DEPRECIATION

At 1 April 2024

21,542

Charge for year

5,609

At 31 March 2025

27,151

NET BOOK VALUE

At 31 March 2025

24,360

At 31 March 2024

18,748

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 April 2024

and 31 March 2025

20

NET BOOK VALUE

At 31 March 2025

20

At 31 March 2024

20

6.

DEBTORS

31.3.25

31.3.24

£

£

Amounts falling due within one year:

Trade debtors

1,776

11,481

Amounts falling due after more than one year:

Other debtors

10,675

-

Aggregate amounts

12,451

11,481

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade creditors

(1

)

(1

)

Taxation and social security

1,775

1,684

Other creditors

12,072

(8,145

)

13,846

(6,462

)

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Other creditors

-

23,425